Fulcrum Therapeutics (FULC)
(Delayed Data from NSDQ)
$7.54 USD
+0.22 (3.01%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $7.55 +0.01 (0.13%) 5:10 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Fulcrum Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
FULC 7.54 +0.22(3.01%)
Will FULC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for FULC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FULC
Fulcrum Therapeutics (FULC) Upgraded to Buy: Here's Why
New Strong Buy Stocks for November 12th
FULC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fulcrum Before Q3 Earnings: How Should Investors Play the Stock?
Fulcrum Stock Tanks 58% in a Month: Buying Opportunity or Risky Bet?
Pacira's Exparel Receives Permanent New Product-Specific J-Code
Other News for FULC
H.C. Wainwright Remains a Buy on Fulcrum Therapeutics (FULC)
FULC forms NR7 on September 17
Is FULC ready to move higher? Crossed Above 50 Day Moving Average shows up after climbing 3.25%
20 Day Moving Average Support appears for FULC after 1.0% move
Fulcrum Therapeutics (FULC) Receives a Sell from Bank of America Securities